A detailed history of Wellington Management Group LLP transactions in Evotec Se stock. As of the latest transaction made, Wellington Management Group LLP holds 2,634,434 shares of EVO stock, worth $11.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,634,434
Previous 2,031,576 29.67%
Holding current value
$11.8 Million
Previous $9.75 Million 1.39%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.96 - $5.34 $1.78 Million - $3.22 Million
602,858 Added 29.67%
2,634,434 $9.62 Million
Q2 2024

Aug 13, 2024

BUY
$4.07 - $7.87 $8.27 Million - $16 Million
2,031,576 New
2,031,576 $9.75 Million

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.59B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.